GHIGLIERI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 1.708
AS - Asia 1.365
EU - Europa 460
SA - Sud America 218
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 10
Totale 3.819
Nazione #
US - Stati Uniti d'America 1.525
SG - Singapore 470
TR - Turchia 351
CN - Cina 339
IT - Italia 213
BR - Brasile 186
CA - Canada 165
VN - Vietnam 97
DE - Germania 83
GB - Regno Unito 43
IN - India 23
IE - Irlanda 22
EU - Europa 20
HK - Hong Kong 20
ZA - Sudafrica 16
RU - Federazione Russa 15
MX - Messico 14
FR - Francia 13
AR - Argentina 12
BD - Bangladesh 11
JP - Giappone 10
NL - Olanda 10
RO - Romania 10
ES - Italia 9
FI - Finlandia 8
ID - Indonesia 8
SE - Svezia 8
AU - Australia 6
EC - Ecuador 6
TW - Taiwan 6
UA - Ucraina 6
CO - Colombia 5
CL - Cile 4
KE - Kenya 4
LT - Lituania 4
MA - Marocco 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
EG - Egitto 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
DK - Danimarca 2
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
KR - Corea 2
LK - Sri Lanka 2
PE - Perù 2
PH - Filippine 2
PL - Polonia 2
SN - Senegal 2
TN - Tunisia 2
VE - Venezuela 2
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LY - Libia 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
RS - Serbia 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.819
Città #
Kocaeli 269
San Mateo 229
Dallas 155
Toronto 149
Rome 116
Singapore 116
Santa Clara 101
Ashburn 95
Houston 92
Lawrence 79
Princeton 79
Wilmington 77
Chandler 63
Beijing 60
Fairfield 33
Shanghai 32
Ho Chi Minh City 31
Frankfurt am Main 29
Los Angeles 26
Munich 25
Redwood City 23
Guangzhou 22
Hanoi 22
Woodbridge 22
Hong Kong 20
Assago 18
Seattle 18
The Dalles 18
New York 15
Shenzhen 14
Chicago 13
São Paulo 13
Columbus 12
Dublin 12
Brooklyn 11
Johannesburg 11
Constanta 10
Falls Church 10
West Jordan 10
Jiaxing 9
Tokyo 9
Council Bluffs 8
Rio de Janeiro 8
Cambridge 7
Chennai 7
Mexico City 7
Stockholm 7
Helsinki 6
Belo Horizonte 5
Bristol 5
London 5
Montreal 5
Pune 5
Suffern 5
Atlanta 4
Curitiba 4
Da Nang 4
Dhaka 4
Guayaquil 4
Haiphong 4
Manaus 4
Rui'an 4
Taipei 4
Wuhan 4
Wuxi 4
Amsterdam 3
Biên Hòa 3
Boardman 3
Boston 3
Cagliari 3
Calgary 3
Chapadinha 3
Charlotte 3
Guarulhos 3
Jakarta 3
Jinhua 3
Joinville 3
Juiz de Fora 3
Mercato Cilento 3
Mogi das Cruzes 3
Moscow 3
Ninh Bình 3
Pittsburgh 3
Poplar 3
Quảng Ngãi 3
Redmond 3
Salvador 3
San Francisco 3
Santo André 3
Trento 3
Weitang 3
Amman 2
Ankara 2
Belém 2
Bolzano 2
Botucatu 2
Buffalo 2
Bắc Ninh 2
Cajamar 2
Campinas 2
Totale 2.388
Nome #
Direct and indirect pathways of basal ganglia: a critical reappraisal 195
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease 92
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 77
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuo-spatial memory alteration. 68
Dopamine drives binge-like consumption of a palatable food in experimental parkinsonism. 65
A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. 63
Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms 62
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor Subunit 60
Corticostriatal synaptic plasticity alterations in the R6/1 transgenic mouse model of Huntington's disease 59
Theta-burst stimulation and striatal plasticity in experimental parkinsonism 58
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 58
NMDA receptor G1uN2D subunit participates to levodopa-induced dyskinesia pathophysiology 58
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap 57
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation. 56
Interaction between basal ganglia and limbic circuits in learning and memory processes 55
Striatal spreading depolarization: possible implication in L-DOPA-induced dyskinetic like-behavior. 55
Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia 54
The Distinct Role of Medium Spiny Neurons and Cholinergic Interneurons in the D-2/A(2A) Receptor Interaction in the Striatum: Implications for Parkinson's Disease 54
Rabphilin 3A: A novel target for the treatment of levodopa-induced dyskinesias 53
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment 53
Striatum-hippocampus balance: From physiological behavior to interneuronal pathology 51
Neural networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 51
Transcranial Magnetic Stimulation Exerts "Rejuvenation" Effects on Corticostriatal Synapses after Partial Dopamine Depletion 51
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 50
Serotonin drives striatal synaptic plasticity in a sex-related manner 50
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? 49
Memantine alters striatal plasticity inducing a shift of synaptic responses toward long-term depression 49
Prenatal stress and hippocampal BDNF expression: a fading imperative 49
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice 48
mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP 47
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced Dyskinesia 46
Dopamine-Dependent Long-Term Depression Is Expressed in Striatal Spiny Neurons of Both Direct and Indirect Pathways: Implications for Parkinson's Disease 46
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 45
Molecular mechanisms underlying levodopa-induced dyskinesia. 45
Plastic abnormalities in experimental Huntington's disease 45
Hyperkinetic disorders and loss of synaptic downscaling 45
Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease 45
A positive allosteric modulator of mGlu4 receptors restores striatal plasticity in an animal model of L-Dopa-induced dyskinesia 44
FUNCTIONAL INTERACTIONS WITHIN STRIATAL MICROCIRCUIT IN ANIMAL MODELS OF HUNTINGTON'S DISEASE 44
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 44
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia 44
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 44
Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson's disease restoring striatal synaptic plasticity 44
L-DOPA reverses the impairment of Dentate Gyrus LTD in experimental parkinsonism via beta-adrenergic receptors 43
The endocannabinoid system in Parkinson's disease. 43
Rebalance of Striatal NMDA/AMPA Receptor Ratio Underlies the Reduced Emergence of Dyskinesia During D2-Like Dopamine Agonist Treatment in Experimental Parkinson's Disease 42
L-3,4-Dihydroxyphenylalanine-Induced Sprouting of Serotonin Axon Terminals: A Useful Biomarker for Dyskinesias? 41
Intermittent Theta-burst Stimulation Rescues Dopamine-Dependent Corticostriatal Synaptic Plasticity and Motor Behavior in Experimental Parkinsonism: Possible Role of Glial Activity 41
Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting 41
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease 40
Environmental Enrichment and Functional Plasticity in the Hippocampus – An Update on the Mechanisms Involved 40
Short-term and long-term plasticity at corticostriatal synapses: implications for learning and memory 39
Rhes influences striatal cAMP/PKA-dependent signaling and synaptic plasticity in a gender-sensitive fashion 39
Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition 38
Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance. 38
Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction 37
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits 37
Impairment of long term depression in dyskinetic rats: A critical role of NO/cGMP pathway in recovering synaptic plasticity 37
Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons 37
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease 36
Striatal synaptic changes in experimental parkinsonism: role of NMDA receptor trafficking in PSD. 36
"Lazy" nigrostriatal synapses in the heterozygous PINK1 mouse model of familial Parkinson's disease 35
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 34
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease 34
Cigarette smoke inhalation stimulates dopaminergic neurons in rats 32
Attachment and parental reflective functioning features in ADHD: Enhancing the knowledge on parenting characteristics 31
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 29
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia 29
Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease 28
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis 28
Striatal glutamatergic hyperactivity in Parkinson's disease 26
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 26
Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: electrophysiological evidence 26
Le emozioni nei contesti individuali e sociali 26
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 25
Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease 24
Neurofunctional effects of developmental alcohol exposure in alcohol-preferring and alcohol-nonpreferring rats 22
Reply to: Rewiring Brains in Parkinson's Disease: The New Era of Brain Stimulation 22
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 22
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease 21
Astrocyte Responses Influence Local Effects of Whole‐Brain Magnetic Stimulation in Parkinsonian Rats 21
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease 20
Alpha-synuclein: From early synaptic dysfunction to neurodegeneration 20
Synaptic dysfunction in Parkinson's disease 20
Environmental enrichment repairs structural and functional plasticity in the hippocampus 20
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 20
Neuro-Immune Cross-Talk in the Striatum: From Basal Ganglia Physiology to Circuit Dysfunction 19
Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat 19
Hippocampal enlargement in Bassoon-mutant mice is associated with enhanced neurogenesis, reduced apoptosis, and abnormal BDNF levels 19
Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release 19
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit 19
Repetitive transcranial magnetic stimulation reduces remote apoptotic cell death and inflammation after focal brain injury 18
Rhes, a key element of selective neuronal vulnerability in Huntington's disease: a striatal-specific license to kill during energy metabolism failure 17
TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid 16
Maternal stress programs accelerated aging of the basal ganglia motor system in offspring 16
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson’s Disease 5
Totale 3.941
Categoria #
all - tutte 42.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021413 0 0 0 0 0 41 31 11 16 24 269 21
2021/2022507 10 141 143 0 3 7 18 50 27 92 9 7
2022/2023336 178 2 3 20 30 6 4 8 15 21 40 9
2023/2024252 0 2 11 60 8 7 1 3 8 25 20 107
2024/2025868 36 205 46 21 40 148 26 76 102 13 42 113
2025/20261.182 203 190 223 221 163 182 0 0 0 0 0 0
Totale 3.941